ArticleClinical rheumatology2008

Reduction of urinary levels of pyridinoline and deoxypyridinoline and serum levels of soluble receptor activator of NF-kappaB ligand by etanercept in patients with rheumatoid arthritis.

Kageyama Yasunori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.